Harrow Health, Inc. (HROW)
NASDAQ: HROW · IEX Real-Time Price · USD
20.85
-0.20 (-0.95%)
Jul 2, 2024, 4:00 PM EDT - Market closed

Harrow Health Revenue

Harrow Health had revenue of $138.68M in the twelve months ending March 31, 2024, with 49.79% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $34.59M with 32.50% year-over-year growth. In the year 2023, Harrow Health had annual revenue of $130.19M with 46.95% growth.

Revenue (ttm)
$138.68M
Revenue Growth
+49.79%
P/S Ratio
5.32
Revenue / Employee
$440,244
Employees
315
Market Cap
737.71M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023130.19M41.60M46.95%
Dec 31, 202288.60M16.12M22.24%
Dec 31, 202172.48M23.61M48.30%
Dec 31, 202048.87M-2.29M-4.48%
Dec 31, 201951.17M9.79M23.67%
Dec 31, 201841.37M14.60M54.52%
Dec 31, 201726.77M6.83M34.26%
Dec 31, 201619.94M10.23M105.25%
Dec 31, 20159.72M8.06M485.30%
Dec 31, 20141.66M1.65M16,500.00%
Dec 31, 201310.00K-90.00K-90.00%
Dec 31, 2012100.00K--
Dec 31, 20110--
Dec 31, 20100--
Dec 31, 20090--
Dec 31, 20080--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Embecta 1.13B
Ginkgo Bioworks Holdings 208.70M
Cytek Biosciences 200.79M
CureVac 64.13M
Mesoblast 7.25M
Dianthus Therapeutics 2.26M
Revenue Rankings